John J. Seman

Mr. John J. Seman is the acting CEO of Canget. Currently, he is actively recruiting a top-notch CEO with a solid track record of success in raising funds to develop and commercialize drugs for leading Canget Series A investment. Mr. Seman began his career in global life science corporations working for E. R. Squibb & Sons and then Johnson & Johnson, holding various management positions in sales, marketing, and business development. During this tenure, he was an important team member responsible for the introduction of a new cardiovascular drug that achieved sales of $100 million in the first year on the market, managed a portfolio of biotech products valued at over $500 million, and actively participated in the licensing and acquisition of multiple pharmaceutical products. His senior management experience includes an executive leadership position focused on expansion of central laboratory services into the global market for Covance, an international contract research organization. The past 20 years have been spent in entrepreneurial startups where he built an innovative technology based company, AVANTEC, to accelerate the receipt of clinical trial data from investigator sites, securing multiple rounds of financing; boot strapped, tripled revenue, and sold a reimbursement services company, HealthBridge; secured initial funding from angel investors for a preclinical research company, PhysioGenix, transforming a SBIR funded company into a revenue generating company; founded an innovative dental pain management company, Amorsus Pharma, and most recently grew public funding by over 50% within the first year for a non-profit medical education organization, IDIS. Mr. Seman holds a Bachelor of Science degree in Pharmacy, and received a Master of Science degree with honors in Pharmaceutical Economics and Business Administration, from the Massachusetts College of Pharmacy. He is an active participant in industry associations, often asked to present at national conferences, and has published articles on bench marking best performance.